BrainWaveBank Limited, an artificial intelligence (‘AI’) company focused on developing a machine learning-enabled neurocognitive platform for in-home assessment and remote monitoring of central nervous system disorders, including neurodegenerative diseases such as Alzheimer’s, and psychiatric conditions such as depression and schizophrenia, has closed a £1.1m financing round led by Par Equity and supported by current investors Techstart Ventures, Co-Fund II managed by Clarendon Fund Managers, Angel CoFund, and new investment from British Business Investments. This is the second investment that Par Equity has made in BrainWaveBank.